Pseudomyxoma peritonei CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==CT==
==CT==
low attenuation, often loculated fluid thoughout the peritoneum, omentum and mesentery.
*Low attenuation, often loculated fluid thoughout the peritoneum, omentum and mesentery
scalloping of visceral surfaces, particularly the liver 5
*Scalloping of visceral surfaces, particularly the liver
scattered (curvilinear or punctate) calcifications may be frequently present 5
*Scattered (curvilinear or punctate) calcifications may be frequently present
tends to remain localised to peritoneal cavity
*Tends to remain localised to peritoneal cavity


== References ==
== References ==
Line 15: Line 15:
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Surgery]]
[[Category:Surgery]]
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 19:24, 18 November 2015

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei CT

CDC on Pseudomyxoma peritonei CT

Pseudomyxoma peritonei CT in the news

Blogs on Pseudomyxoma peritonei CT

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

CT

  • Low attenuation, often loculated fluid thoughout the peritoneum, omentum and mesentery
  • Scalloping of visceral surfaces, particularly the liver
  • Scattered (curvilinear or punctate) calcifications may be frequently present
  • Tends to remain localised to peritoneal cavity

References


Template:WikiDoc Sources